Applied to one case of the local molecular inflammatory board the external diagnosis of therapy-refractory GERD could be revised to CD and a potential drug target (ICAM1) was identified as high abundant resulting in CiclosporinA as a personalized treatment recommendation. The gene discussed is ICAM1; the disease is gastroesophageal reflux disease.